| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |